Xmax Inc
6 nominees · 4 ballot items.
Stockholders are asked to ratify certain March and April 2026 issuances, approve two Nasdaq-compliant offerings of up to 15 million shares each at below-Minimum-Price terms, and authorize the Chairman to adjourn the Special Meeting to solicit additional proxies.
Follow how the vote landed and what changed on Xmax Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot4
- 1
Ratification Proposal
ManagementBoard: FORRatify the March 9, March 30, and April 24, 2026 private placement transactions and related issuances of 8,500,000, 1,958,000, and 8,550,000 shares, respectively, which were issued below Nasdaq’s Minimum Price and, together with a prior December issuance, exceeded 20% of the Company’s outstanding common stock.
More detail
Proposal 1 asks stockholders to ratify three private placement issuances completed on March 9, March 30, and April 24, 2026. The transactions involved 8.5 million, 1.958 million, and 8.55 million shares, respectively, issued at prices below Nasdaq’s defined Minimum Price. The Company explains that these issuances, when aggregated with a 1.1875 million-share December 2025 issuance, exceeded 20% of the pre-transaction outstanding common stock. Nasdaq notified the Company that the aggregated transactions may not comply with Listing Rule 5635(d), which requires prior stockholder approval for certain below-Minimum-Price issuances. The Company therefore seeks after-the-fact approval and ratification as part of its plan to regain compliance. Continued listing on The Nasdaq Capital Market is presented as a central corporate objective and the principal rationale for the proposal. The Company submitted a compliance plan to Nasdaq on September 30, 2026 and is awaiting Nasdaq’s response. Approval could support an extension or other compliance process, but the filing expressly warns that ratification may not satisfy Nasdaq. The Board unanimously recommends a vote FOR the proposal because it believes ratification is in the best interests of the Company and its stockholders.
- 2
Private Placement Issuance Proposal
ManagementBoard: FORApprove, under Nasdaq Listing Rule 5635(d), a private placement of up to 15,000,000 shares at prices below the Nasdaq Minimum Price, for aggregate proceeds of up to $85,000,000, to fund the Company’s AI-focused business strategy and support its Nasdaq listing.
More detail
Proposal 2 asks stockholders to approve a prospective private placement that could issue up to 15 million shares of common stock. The offering would be conducted under Section 4(a)(2) of the Securities Act and/or Regulation S and would involve a price below Nasdaq’s Minimum Price. Nasdaq approval is required because the issuance could exceed 20% of the Company’s outstanding common stock. The Company says it needs the proceeds to pursue a new business strategy focused on AI software and hardware, cloud and GPU infrastructure, AI model access and orchestration, and enterprise AI agents. The proposal caps total proceeds at $85 million and requires issuance to be completed within three months after stockholder approval. It also permits a discount of up to 50% of the prior trading day’s Nasdaq closing price, subject to other stated terms. The Company will not sell securities in the offering to its officers, directors, or employees. Management acknowledges that the issuance would dilute existing stockholders and could concentrate voting power if a purchaser acquires a large block. The Board unanimously recommends voting FOR because the offering could provide rapid capital while helping the Company maintain its Nasdaq listing.
- 3
Shelf Issuance Proposal
ManagementBoard: FORApprove, under Nasdaq Listing Rule 5635(d), a registered direct offering of up to 15,000,000 shares at prices below the Nasdaq Minimum Price, for aggregate proceeds of up to $85,000,000, under the Company’s effective Form S-3 registration statement.
More detail
Proposal 3 asks stockholders to approve a registered direct offering of up to 15 million shares under the Company’s effective Form S-3 registration statement No. 333-295406. Like Proposal 2, the offering would be priced below Nasdaq’s Minimum Price and may exceed 20% of the Company’s outstanding common stock. The Company states that Nasdaq Listing Rule 5635(d) requires stockholder approval for this type of issuance. Management intends to use the capital to support expansion into AI software and hardware, cloud and GPU compute infrastructure, AI model orchestration, and enterprise AI agents. The proposal limits aggregate proceeds to $85 million and requires completion within three months after stockholder approval. It allows a discount of up to 50% of the prior trading day’s Nasdaq closing price, subject to the other terms approved by the Board. Officers, directors, and employees will not be eligible purchasers in the offering. The filing warns that the issuance will dilute current holders and could result in concentrated voting power among purchasers of a large block. The Board unanimously recommends voting FOR because approval would facilitate a rapid capital raise and support continued Nasdaq listing.
- 4
Adjournment
ManagementBoard: FORAuthorize the Chairman of the Board to adjourn the Special Meeting, if necessary, to solicit additional proxies in favor of Proposals 1, 2, and 3.
More detail
Proposal 4 asks stockholders to grant the Chairman discretionary authority to adjourn the Special Meeting. The stated purpose is to solicit additional proxies supporting Proposals 1, 2, and 3 if the Company lacks sufficient votes. An adjournment could be made without additional notice beyond an announcement at the meeting. The filing states that approval of an adjournment may occur by holders of a majority of shares present in person or by proxy and entitled to vote, whether or not a quorum exists. The Chairman would decide whether to exercise the authority if it is approved. The proposal is procedural and does not itself authorize any securities issuance or ratification. Its practical effect would be to give management more time to obtain stockholder support for the financing and Nasdaq-compliance proposals. Broker non-votes and abstentions will not be counted in determining the outcome. The Board unanimously recommends voting FOR the proposal because additional solicitation may be needed to secure approval of Proposals 1, 2, and 3.
Nominees on the ballot6
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 3.9% | 2,485,752 | $23M |
| 2 | BlackRock, Inc. | 3.7% | 2,374,333 | $22M |
| 3 | BlackRock, Inc. | 2.6% | 1,702,874 | $15M |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 2.0% | 1,292,191 | $12M |
| 5 | STATE STREET CORP | 1.5% | 954,275 | $9M |
| 6 | NORTHERN TRUST CORP | 0.8% | 484,391 | $4M |
| 7 | VANGUARD FIDUCIARY TRUST CO | 0.7% | 443,462 | $4M |
| 8 | VANGUARD PORTFOLIO MANAGEMENT LLC | 0.7% | 422,802 | $4M |
| 9 | UBS Group AG | 0.6% | 355,109 | $3M |
| 10 | RENAISSANCE TECHNOLOGIES LLC | 0.5% | 323,335 | $3M |
Other Consumer Cyclical sector meetings6
Upcoming shareholder meetings at Xmax Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Xmax Inc 2026 special meeting?
- Xmax Inc (XMAX) holds its 2026 special shareholder meeting on Monday, November 2, 2026.
- What is the record date for the Xmax Inc 2026 meeting?
- The record date for the Xmax Inc 2026 meeting is Tuesday, September 15, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Xmax Inc's 2026 meeting?
- The board is presenting 6 director nominees at the Xmax Inc 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Xmax Inc 2026 meeting?
- Shareholders will vote on 4 proposals at the Xmax Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.